John Berdahl

John Berdahl is a Scientific Advisor at Kedalion Therapeutics. John has also worked as Melt Pharmaceuticals, Equinox Ophthalmic, Inc., and Vance Thompson Vision. John received their training in Ophthalmology from Duke University where they were awarded the Ophthalmology Times Writers Award 1st pl - National Award, Resident of the Year Award (2008), and the Machemer Research Award (2007 & 2008).

John Berdahl's educational career began with a Bachelor's Degree in Physics, Chemistry, Biology from Augustana University (SD). John then attended Mayo Clinic School of Medicine where they received their Doctor of Medicine (M.D.). After completing their M.D., they did a Transitional Internship Year in the field of Transitional Internship Year at Mayo Clinic Scottsdale. John then went on to complete a Fellowship in Cornea, External Disease, Glaucoma, and Refractive Surgery at Minnesota Eye Consultants. Lastly, they did a Residency Training in Ophthalmology at Duke University School of Medicine.